Are Options Traders Bullish on ARGX?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About ARGX

Argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Argenx is focused on developing product candidates with the potential to be either first-in-class against novel targets or best-in-class against known, but complex, targets in order to treat diseases with a significant unmet medical need. Argenx ability to execute on this focus is enabled by its suite of differentiated technologies. Argenx SIMPLE Antibody(TM) Platform, based on the powerful llama immune system, allows it to exploit novel and complex targets, and its three antibody engineering technologies are designed to enable it to expand the therapeutic index of its product candidates.
Primary Exchange: NASDAQ

ARGX is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ADRD Invesco BLDRS Developed Markets 100 ADR Index Fund 49.9 M 4.99E+07 83 83 0.09% 0.00093 46 K 46044
ADRU Invesco BLDRS Europe Select ADR Index Fund 12.8 M 1.28E+07 69 69 0.11% 0.00113 14 K 14382
BIB ProShares Ultra Nasdaq Biotechnology 271.3 M 2.71337E+08 235 235 0.11% 0.00113556 675 K 675402
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.22135E+09 224 224 0.32% 0.0032 25.5 M 2.54611E+07
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,016 1016 0.01% 0.000108268 185 K 184901
UBIO Proshares UltraPro Nasdaq Biotechnology 34.1 M 3.40656E+07 229 229 0.06% 0.000630205 71 K 71407

Wait, Before You Leave...